Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2)
about
Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization.Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery.The N-terminal HSDCIF motif is required for cell surface trafficking and dimerization of family B G protein coupled receptor PAC1.Receptor oligomerization in family B1 of G-protein-coupled receptors: focus on BRET investigations and the link between GPCR oligomerization and binding cooperativity.Dimerization in the absence of higher-order oligomerization of the G protein-coupled secretin receptor.Conformational switches in the VPAC(1) receptor.Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studiesReceptor oligomerization: from early evidence to current understanding in class B GPCRs.
P2860
Q34079450-CAC0E2F5-1FAE-4273-B5FD-160046DA34DCQ34454930-8DD5CDBE-CBB2-4812-8097-7544D5648F48Q34532319-16FD905F-DE52-4D72-BC3E-106E973DA4E8Q35971449-E523DA39-214F-43A0-8C97-4B0CEA8F01AAQ37177027-7B051660-A41F-4EBB-B422-CC8A3A7F5543Q37909492-6D79AAEA-FE51-4A59-83B6-6875C08B2B8AQ41645695-5D6BDA13-0609-47FC-BF17-8766E29FB7A4Q42567375-69967B31-EA2E-499B-BD5A-30BBBDA78414
P2860
Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2)
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pharmacological properties of ...... receptors (hVPAC1 and hVPAC2)
@ast
Pharmacological properties of ...... receptors (hVPAC1 and hVPAC2)
@en
type
label
Pharmacological properties of ...... receptors (hVPAC1 and hVPAC2)
@ast
Pharmacological properties of ...... receptors (hVPAC1 and hVPAC2)
@en
prefLabel
Pharmacological properties of ...... receptors (hVPAC1 and hVPAC2)
@ast
Pharmacological properties of ...... receptors (hVPAC1 and hVPAC2)
@en
P2093
P2860
P356
P1476
Pharmacological properties of ...... receptors (hVPAC1 and hVPAC2)
@en
P2093
Ingrid Langer
Nathalie Gaspard
Patrick Robberecht
P2860
P304
P356
10.1038/SJ.BJP.0706816
P407
P577
2006-06-19T00:00:00Z